Bromodomain inhibitor-9 is aBromodomainsinhibitor that selectively inhibits BRD4-1 (K_d: 12 nM). Bromodomain inhibitor-9 can be used in the research of diseases or conditions associated with systemic or tissue inflammation, lipid metabolism, fibrosis or chronic autoimmune diseases^[1].

Bromodomain inhibitor-9 (Compound 99, 1 h) inhibits LPS induced cytokines (IL12P40) release in PBMCs, with an IC₅₀value of 400 nM^[1].

484.57

C₂₄H₂₈N₄O₅S

1870849-34-5

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.